Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

CASTIGLIA, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.334
EU - Europa 1.164
AS - Asia 291
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
AF - Africa 1
Totale 5.800
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.328
IT - Italia 496
CN - Cina 229
DE - Germania 132
FI - Finlandia 120
RU - Federazione Russa 82
IE - Irlanda 78
GB - Regno Unito 72
BE - Belgio 42
SE - Svezia 38
UA - Ucraina 29
IN - India 21
FR - Francia 18
RO - Romania 18
TR - Turchia 11
NL - Olanda 10
KR - Corea 9
IR - Iran 8
CH - Svizzera 7
CA - Canada 6
ES - Italia 6
HK - Hong Kong 6
DK - Danimarca 4
AR - Argentina 2
AT - Austria 2
AU - Australia 2
BR - Brasile 2
CL - Cile 2
CZ - Repubblica Ceca 2
EU - Europa 2
SG - Singapore 2
TW - Taiwan 2
AL - Albania 1
BG - Bulgaria 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
JP - Giappone 1
KW - Kuwait 1
MC - Monaco 1
MK - Macedonia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
Totale 5.800
Salva come PNG Salva come JPEG
Città #
Fairfield 841
Ashburn 415
Woodbridge 371
Chandler 359
Seattle 330
Wilmington 312
Cambridge 287
Houston 278
Ann Arbor 247
Palermo 148
Dublin 77
Medford 74
Des Moines 67
Nanjing 54
Altamura 50
Dearborn 50
New York 50
Princeton 49
Saint Petersburg 42
Brussels 40
San Diego 40
Lawrence 37
Boardman 29
Ludwigshafen am Rhein 27
Shenyang 23
Jinan 22
Beijing 15
Bremen 15
Jiaxing 15
Phoenix 15
Tulsa 14
Nanchang 13
Redwood City 12
Changsha 11
Hebei 11
Kumar 11
San Paolo di Civitate 11
London 10
Ningbo 10
Tianjin 10
Helsinki 9
Falls Church 8
Hangzhou 8
Jacksonville 8
Hanover 7
Izmir 7
Seongnam 7
Aversa 6
Nürnberg 6
Orange 6
Pune 6
Rome 6
Tehran 6
Zhengzhou 6
Venice 5
Washington 5
Cagliari 4
Hong Kong 4
Milan 4
Norwalk 4
Tappahannock 4
Agrigento 3
Amsterdam 3
Chicago 3
Dordrecht 3
Edinburgh 3
Guangzhou 3
Islington 3
Monreale 3
Moscow 3
Naples 3
Baotou 2
Bari 2
Chengdu 2
Duezce 2
Florence 2
Frankfurt am Main 2
Fremont 2
Groningen 2
Kilburn 2
Kunming 2
Madrid 2
Messina 2
Osio Sotto 2
Pavia 2
San Mateo 2
Siracusa 2
Taiyuan 2
Walnut 2
Xian 2
Zola Predosa 2
Zurich 2
Absecon 1
Alexandria 1
Arlon 1
Auburn Hills 1
Bagheria 1
Bologna 1
Bolzano 1
Bratislava 1
Totale 4.698
Salva come PNG Salva come JPEG
Nome #
EGFR inhibition in NSCLC: New findings…. and opened questions? 246
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 210
Dietary restriction: could it be considered as speed bump on tumor progression road? 205
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 191
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 186
Liquid Biopsy in Breast Cancer 179
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 172
E26The effects of LIPUS on ctDNA release in the medium of NSCLC cell lines 172
Immunohistochemical/histochemical double staining method in the study of columnar metaplasia of the oesophagus 169
A headlight on liquid biopsies: a challenging tool for breast cancer management 168
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 166
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 159
Nintedanib in NSCLC: Evidence to date and place in therapy 159
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 155
Spheroids from adipose-derived stem cells exhibit an miRNA profile of highly undifferentiated cells 150
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 147
Improvement in Lung Cancer Outcomes With Targeted Therapies: An Update for Family Physicians. 147
Exosomes isolation and characterization in serum is feasible in non-small cell lung cancer patients: critical analysis of evidence and potential role in clinical practice 147
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 146
Immunotherapy: is a minor god yet in the pantheon of treatments for lung cancer? 140
Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects 139
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 137
Adipose tissue, angiogenesis and angio-MIR under physiological and pathological conditions 134
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 132
Exosomal miRNA analysis in non-small cell lung cancer (NSCLC) patients' plasma through qPCR: A feasible liquid biopsy tool 129
Cancer and the microbiome: Potential applications as new tumor biomarker 128
Liquid biopsies in lung cancer: The new ambrosia of researchers 126
Liquid Biopsy in Non-Small Cell Lung Cancer (NSCLC) 126
Involvement of non-coding RNAs in chemo- and radioresistance of colorectal cancer 116
Prognostic and predictive biomarkers for targeted therapy in NSCLC: For whom the bell tolls? 109
Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNAs): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs 101
Liquid Biopsy in Gynecological Cancers 96
Liquid Biopsy in Gastrointestinal Stromal Tumor 87
Hereditary breast and ovarian cancer in families from southern Italy (Sicily)—Prevalence and geographic distribution of pathogenic variants in BRCA1/2 genes 82
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 81
An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesistargeting TKI-based therapy 80
Cell quality evaluation with gene expression analysis of spheroids (3D) and adherent (2D) adipose stem cells 78
MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER 76
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 75
Erratum to: The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis (Scientific Reports, (2018), 8, 1, (13379), 10.1038/s41598-018-30780-4) 72
null 69
Circulating tumor DNA (ctDNA) as predictive biomarker in NSCLC patients treated with Nivolumab 68
The role of microRNAs in driving EGFR-TKI resistance in NSCLC cell lines 68
ALK and crizotinib: After the honeymoon...what else? Resistance mechanisms and new therapies to overcome it 67
Into the wild of long non-coding RNA in gastrointestinal stromal tumors (GISTs) to explore new prognostic/predictive biomarkers 62
Corrigendum to "Liquid biopsies in lung cancer: The new ambrosia of researchers" [Biochem. Biophys. Act. 1846(2014) 539-546] 57
Molecular analysis of Spheroids from Adipose-derived Stem Cells (S-ASCs) during in vitro long-term culture. 53
The prognostic role of KRAS and BRAF in patients undergoing surgical resection of colorectal cancer liver metastasis: a systematic review and meta-analysis 37
HEREDITARY BREAST AND OVARIAN CANCER SYNDROME: FREQUENCY AND DISTRIBUTION OF BRCA1/2 PATHOGENIC VARIANTS IN SICILIAN POPULATION 36
LIQUID BIOPSY AS A DYNAMIC TOOL FOR LUNG CANCER MANAGEMENT: A FEASIBILITY STUDY FOR PLASMA-DERIVED EXOSOMAL miRNAs AND CELL-FREE DNA. 26
null 25
Technical Aspects for the Evaluation of Circulating Tumor Cells (CTCs) 13
null 6
P2.06: Exosomal miRNA Analysis in Non-Small Cell Lung Cancer: New Liquid Biomarker?: Track: Biology and Pathogenesis 1
Totale 6.106
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.134
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.134
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019392 0 0 0 0 0 0 0 0 0 62 166 164
2019/20202.024 202 126 156 409 197 213 167 136 142 106 127 43
2020/2021922 87 19 66 67 72 68 71 65 90 141 113 63
2021/2022675 49 138 31 26 30 39 31 38 74 72 45 102
2022/2023981 94 180 25 144 107 144 63 73 95 5 32 19
2023/2024349 17 68 26 37 20 95 52 29 3 2 0 0
Totale 6.106